This webcast features: Kira Hedström, Application Scientist, Gyros Protein Technologies. The biotherapeutic landscape has shifted. While monoclonal antibodies remain a cornerstone of the pipeline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results